Teleflex (TFX) Stock Price, News & Analysis

Company Overview

Teleflex Incorporated is a global medical technology company that develops, manufactures and markets specialty medical devices. Its products are designed to support healthcare professionals in critical care and procedural settings, including vascular access, interventional cardiology and radiology, anesthesia, respiratory care, emergency medicine, surgical applications and urology.

The company’s portfolio includes catheters, access and closure devices, airway-management products, surgical instruments, pain-management devices and other technologies used in hospitals and outpatient facilities. Teleflex markets products under brands that include Arrow, MANTA, LMA, Rüsch, Hudson RCI and QuikClot, among others.

Teleflex serves healthcare providers in North America, Europe, Asia and other international markets. The company traces its roots to 1943 and has expanded its medical technology business through internal development and acquisitions. Its corporate headquarters are in Wayne, Pennsylvania.

Key Stats

• Today's Range: $138.33 to $141.59
• 50-Day Range: $120.15 to $142.08
• 52-Week Range: $100.18 to $145.00
• Volume: 923,082 shs
• Average Volume: 682,097 shs
• Market Capitalization: $5.95 billion
• P/E Ratio: 15.88
• Dividend Yield: 0.97%
• Price Target: $154.40
• Consensus Rating: Moderate Buy

Teleflex Stock Analysis - MarketRank™

Teleflex scored higher than 76% of companies evaluated by MarketBeat, and ranked 412th out of 901 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.0 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Teleflex has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 strong buy rating, 5 buy ratings, 5 hold ratings, and 1 sell rating.

Upside/Downside

The consensus price target for Teleflex is close to its current price, suggesting limited near-term upside or downside.

Amount of Analyst Coverage

Teleflex has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 4.4 / 5
• Proj. Earnings Growth: 50.83%

Earnings Growth

Earnings for Teleflex are expected to grow by 50.83% in the coming year, from $7.22 to $10.89 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Teleflex is 15.88, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.62.

Price to Earnings Ratio vs. Sector

The P/E ratio of Teleflex is 15.88, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 36.69.

Price to Earnings Growth Ratio

Teleflex has a PEG Ratio of 0.93. PEG Ratios below 1 indicate that a company could be undervalued.

Price to Book Value per Share Ratio

Teleflex has a P/B Ratio of 1.99. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

10.02% of the float of Teleflex has been sold short.

Short Interest Ratio / Days to Cover

Teleflex has a short interest ratio ("days to cover") of 5.98.

Change versus previous month

Short interest in Teleflex has recently increased by 4.09%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.8 / 5
• Dividend Strength: Weak

Dividend Yield

Teleflex has a dividend yield of 0.98%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

Teleflex does not have a long track record of dividend growth.

Dividend Sustainability

Based on earnings estimates, Teleflex will have a dividend payout ratio of 12.49% next year. This indicates that Teleflex will be able to sustain or increase its dividend.

News and Social Media

• Score: 1.6 / 5
• News Sentiment: 0.54

News Sentiment

Teleflex has a news sentiment score of 0.54. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.65 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 5 news articles for Teleflex this week, compared to 6 articles on an average week.

MarketBeat Follows

Only 1 people have added Teleflex to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 0.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Teleflex insiders have not sold or bought any company stock.

Percentage Held by Insiders

0.70% of the stock of Teleflex is held by insiders.

Percentage Held by Institutions

95.62% of the stock of Teleflex is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/06/2026
• Record date for 9/30 Dividend: 8/14/2026
• Ex-Dividend for 9/30 Dividend: 8/14/2026
• Dividend Payable: 9/30/2026
• Today: 11/02/2026
• Next Earnings (Estimated): 11/05/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: NYSE:TFX
• CIK: 96943
• Web: www.teleflex.com
• Phone: (610) 225-6800
• Fax: 215-553-5402
• Employees: 15,500
• Year Founded: 1943

Price Target and Rating

• Average Price Target for Teleflex: $154.40
• High Price Target: $170.00
• Low Price Target: $138.00
• Potential Upside/Downside: +9.9%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.50
• Research Coverage: 12 Analysts

Profitability

• EPS (Trailing Twelve Months): ($23.29)
• Trailing P/E Ratio: 15.88
• Forward P/E Ratio: 12.91
• P/E Growth: 0.93
• Net Income: -$905.64 million
• Net Margins: -39.67%
• Pretax Margin: -2.44%
• Return on Equity: 11.93%
• Return on Assets: 5.44%

Debt

• Debt-to-Equity Ratio: 0.94
• Current Ratio: 2.60
• Quick Ratio: 2.12

Sales & Book Value

• Annual Sales: $1.99 billion
• Price / Sales: 2.99
• Cash Flow: $11.32 per share
• Price / Cash Flow: 12.42
• Book Value: $70.71 per share
• Price / Book: 1.99

Miscellaneous

• Outstanding Shares: 42,370,000
• Free Float: 42,075,000
• Market Cap: $5.95 billion
• Optionable: Optionable
• Beta: 0.83